文献速递临床试验与 GCP基础与转化研究

针刺治疗肠易激综合征:多中心随机对照试验研究方案

Acupuncture for irritable bowel syndrome: study protocol for a multicenter randomized controlled trial.
PubMed 文献 · Trials · 2018-10-01

主要结局为IBS症状严重度量表(IBS-SSS),次要结局为IBS生活质量量表(IBS-QoL),并探索IBS基因亚型与针刺疗效的相关性。

要点

  • 针刺组与西药组对照,治疗6周、随访3个月。
  • 主要结局为IBS-SSS,次要结局为IBS-QoL。
  • 探索IBS基因亚型与针刺疗效的相关性。

核心结论

  • 该研究旨在评估针刺作为肠易激综合征替代疗法的疗效与安全性,并首次基于基因组学探索IBS潜在机制。

研究设计与样本

  • 患者按IBS-C或IBS-D分层后,层内随机分为针刺组与西药组。
  • 所有患者接受6周治疗和3个月随访,结局在基线、干预1周、2周、4周、6周及干预后12周收集。

关键数值与推荐

  • 主要结局为IBS症状严重度量表(IBS-SSS),次要结局为IBS生活质量量表(IBS-QoL)。
  • IBS基因亚型与针刺疗效的相关性基于聚合酶链反应-限制性片段长度多态性(PCR-RFLP)检测。
  • 试验注册于中国临床试验注册中心,ID为ChiCTR-IOR-15006259,首次注册日期2015年4月14日。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Irritable bowel syndrome (IBS) is a chronic gastrointestinal disorder characterized by abdominal pain and change of bowel habit without organic disease. A global perspective given by the World Gastroenterology Organization (WGO) points out that IBS can impact the quality of an individual's daily life, cause socioeconomic problems and potentially impair the patient-physician relationship. It remains a problem to treat IBS due to the complicated pathophysiology. Acupuncture is an alternative therapy recommended for IBS. The aim of this study is to investigate the efficacy and safety of acupuncture therapy for patients with IBS. We also want to explore the correlation between IBS-gene subtypes and acupuncture effect. METHODS/DESIGN: A multicenter randomized controlled trial will be performed in seven hospitals. Six hundred participants will be stratified into two strata (IBS-C or IBS-D). Then, patients within each stratum will be divided into an experimental group and a control group randomly. The experimental group is treated with acupuncture while the control group is treated with Western medicine. All the patients will receive a 6-week treatment and a 3-month follow-up. The primary outcome is the IBS-Symptom Severity Score (IBS-SSS), the secondary outcome is the score of the IBS-Quality of Life (IBS-QoL).The correlation between IBS-gene subtypes and acupuncture effect will be detected based on polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Outcome measures (including primary and secondary outcome measures) are collected at baseline,1 week, 2 weeks, 4 weeks, and 6 weeks of the intervention, and 12 weeks after the intervention. DISCUSSION: This is a multicenter randomized controlled trial for IBS in China. It may clarify the efficacy of acupuncture as an alternative therapy for IBS. This is the first time ever that the potential mechanism of IBS based on genomics has been investigated. TRIAL REGISTRATION: Chinese Clinical Trials Register, ID: ChiCTR-IOR-15006259 . First registered on 14 April 2015.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Pei LX, Geng H, Chen H, et al. Acupuncture for irritable bowel syndrome: study protocol for a multicenter randomized controlled trial. Trials. 2018. PMID: 30285891. doi:10.1186/s13063-018-2922-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。